Literature DB >> 28373464

Effects of Lidocaine on HT-29 and SW480 Colon Cancer Cells In Vitro.

Anika C Bundscherer1, Manuela Malsy2, Diane I Bitzinger2, Christoph H R Wiese3, Michael A Gruber2, Bernhard M Graf2.   

Abstract

BACKGROUND: Evidence is growing that the risk of cancer dissemination may be enhanced during the perioperative period. Whether particular anesthetic techniques influence oncological outcome is still under discussion. For pain management, lidocaine can be administered perioperatively by intravenous, intraperitoneal or epidural infusion. Here we investigated the effect of lidocaine on colon carcinoma cell lines (HT-29 and SW480) in vitro.
MATERIALS AND METHODS: ELISA BrdU (Roche) for cell proliferation and FITC Annexin V detection kit (BD Pharming) for apoptosis analysis were applied. Cell-cycle profiles were investigated by flow cytometry.
RESULTS: Cell-cycle arrest was induced in both cell lines by 1000 μM lidocaine, while no inhibition of cell proliferation was detected. Apoptosis decreased in SW480 but not in HT-29 cells.
CONCLUSION: Lidocaine induces cell-cycle arrest in both colon carcinoma cell lines in vitro. The effective drug concentration can be obtained by local infiltration. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Lidocaine; apoptosis; cell cycle; cell proliferation; local anesthetics

Mesh:

Substances:

Year:  2017        PMID: 28373464     DOI: 10.21873/anticanres.11534

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  Lidocaine protects H9c2 cells from hypoxia-induced injury through regulation of the MAPK/ERK/NF-κB signaling pathway.

Authors:  Haibin Jin; Jin Yu
Journal:  Exp Ther Med       Date:  2019-09-26       Impact factor: 2.447

2.  Lidocaine enhances the efficacy of palbociclib in triple-negative breast cancer.

Authors:  Beom Seok Han; Kyung Hee Jung; Ji Eun Lee; Young-Chan Yoon; Soyeon Ko; Min Seok Park; Yun Ji Lee; Sang Eun Kim; Ye Jin Cho; Pureunchowon Lee; Joo Han Lim; Eunsoo Jang; Hyunzu Kim; Soon-Sun Hong
Journal:  Am J Cancer Res       Date:  2022-07-15       Impact factor: 5.942

3.  Effects of Lidocaine-Mediated CPEB3 Upregulation in Human Hepatocellular Carcinoma Cell Proliferation In Vitro.

Authors:  Hongjun Liu; Yiru Wang; Bing Chen; Xia Shen; Wenxian Li
Journal:  Biomed Res Int       Date:  2018-04-17       Impact factor: 3.411

4.  Lidocaine inhibits the progression of retinoblastoma in vitro and in vivo by modulating the miR‑520a‑3p/EGFR axis.

Authors:  Weiyi Xia; Libo Wang; Dongyi Yu; Xing Mu; Xin Zhou
Journal:  Mol Med Rep       Date:  2019-06-06       Impact factor: 2.952

Review 5.  Can Acute Postoperative Pain Management After Tumour Resection Surgery Modulate Risk of Later Recurrence or Metastasis?

Authors:  Aneurin Moorthy; Aisling Ní Eochagáin; Donal J Buggy
Journal:  Front Oncol       Date:  2021-12-16       Impact factor: 6.244

6.  Lidocaine inhibited migration of NSCLCA549 cells via the CXCR4 regulation.

Authors:  Baichun Xing; Linlin Yang; Yanan Cui
Journal:  Cancer Biomark       Date:  2022       Impact factor: 3.828

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.